Select Publications
Journal articles
2014, 'Cortical hyperexcitability and the split-hand plus phenomenon: Pathophysiological insights in ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, pp. 250 - 256, http://dx.doi.org/10.3109/21678421.2013.872150
,2014, 'Early identification of 'acute-onset' chronic inflammatory demyelinating polyneuropathy', Brain, 137, pp. 2155 - 2163, http://dx.doi.org/10.1093/brain/awu158
,2014, 'Emotion processing deficits distinguish pure amyotrophic lateral sclerosis from frontotemporal dementia', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15, pp. 39 - 46, http://dx.doi.org/10.3109/21678421.2013.809763
,2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022
,2014, 'Guillain-Barré syndrome in Asia', Journal of Neurology, Neurosurgery and Psychiatry, 85, pp. 905 - 911, http://dx.doi.org/10.1136/jnnp-2013-306212
,2014, 'Motor cortical function and the precision grip', Physiological Reports, 2, http://dx.doi.org/10.14814/phy2.12120
,2014, 'Remembrance of things future', Journal of Neurology, Neurosurgery and Psychiatry, 85, pp. 1, http://dx.doi.org/10.1136/jnnp-2013-307129
,2014, 'Reply: Botulinum toxin injection for post-stroke spasticity', Muscle and Nerve, 49, pp. 932 - 933, http://dx.doi.org/10.1002/mus.24221
,2014, '13.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.027
,2014, '14.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2037, http://dx.doi.org/10.1016/j.jocn.2014.06.028
,2014, '14. Sensory axonal dysfunction in asymptomatic diabetic patients', Clinical Neurophysiology, 125, pp. e5 - e6, http://dx.doi.org/10.1016/j.clinph.2013.10.036
,2014, '15.', Journal of Clinical Neuroscience, 21, pp. 2037 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.029
,2014, '16.', Journal of Clinical Neuroscience, 21, pp. 2038 - 2038, http://dx.doi.org/10.1016/j.jocn.2014.06.030
,2014, '28.', Journal of Clinical Neuroscience, 21, pp. 2042 - 2042, http://dx.doi.org/10.1016/j.jocn.2014.06.042
,2014, '3. Diagnostic utility of threshold tracking TMS in ALS: Comparative study to Awaji criteria', Clinical Neurophysiology, 125, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2013.10.025
,2014, '30.', Journal of Clinical Neuroscience, 21, pp. 2042 - 2043, http://dx.doi.org/10.1016/j.jocn.2014.06.044
,2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028
,2014, '60.', Journal of Clinical Neuroscience, 21, pp. 2052 - 2052, http://dx.doi.org/10.1016/j.jocn.2014.06.074
,2014, '63.', Journal of Clinical Neuroscience, 21, pp. 2052 - 2053, http://dx.doi.org/10.1016/j.jocn.2014.06.077
,2014, '66.', Journal of Clinical Neuroscience, 21, pp. 2053 - 2054, http://dx.doi.org/10.1016/j.jocn.2014.06.080
,2014, '7. Effects of fampridine PR on axonal function in multiple sclerosis', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.029
,2014, '8. Evolution and recovery of motor function post-stroke', Clinical Neurophysiology, 125, pp. e3 - e4, http://dx.doi.org/10.1016/j.clinph.2013.10.030
,2014, 'Apraxia and motor dysfunction in corticobasal syndrome', PloS One, 9, pp. e92944 - e92944, http://dx.doi.org/10.1371/journal.pone.0092944
,2014, 'Decision-making under uncertainty in advanced heart failure.', Curr Heart Fail Rep, 11, pp. 188 - 196, http://dx.doi.org/10.1007/s11897-014-0195-7
,2014, 'Determinants of survival following hospitalization for acute heart failure.', Curr Heart Fail Rep, 11, pp. 201 - 211, http://dx.doi.org/10.1007/s11897-014-0190-z
,2014, 'Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle.', Muscle Nerve, 49, pp. 829 - 835, http://dx.doi.org/10.1002/mus.24086
,2014, 'Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile', JAMA neurology, 71, pp. 331 - 339, http://dx.doi.org/10.1001/jamaneurol.2013.6002
,2014, 'O54: Diagnostic utility of cortical hyperexcitability in amyotrophic lateral sclerosis', Clinical Neurophysiology, 125, pp. S44 - S44, http://dx.doi.org/10.1016/s1388-2457(14)50157-5
,2014, 'Semantic deficits in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, pp. 1 - 8, http://dx.doi.org/10.3109/21678421.2014.987301
,2013, 'Motor cortex excitability in acute cerebellar infarct', Cerebellum, 12, pp. 826 - 834, http://dx.doi.org/10.1007/s12311-013-0493-8
,2013, 'Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.', Journal of Neurology, 261, pp. 238 - 239, http://dx.doi.org/10.1007/s00415-013-7197-3
,2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204
,2013, 'Circulating fibrocytes and Crohn's disease', BRITISH JOURNAL OF SURGERY, 100, pp. 1549 - 1556, http://dx.doi.org/10.1002/bjs.9302
,2013, 'Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial', LANCET NEUROLOGY, 12, pp. 1059 - 1067, http://dx.doi.org/10.1016/S1474-4422(13)70221-7
,2013, 'Muscle-specific kinase antibodies: A novel cause of peripheral nerve hyperexcitability?', Muscle and Nerve, 48, pp. 819 - 823, http://dx.doi.org/10.1002/mus.23907
,2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324
,2013, 'Pathophysiological Changes in the H-Reflex Pathway in Amyotrophic Lateral Sclerosis (P07.075)', Neurology, 80, http://dx.doi.org/10.1212/wnl.80.7_supplement.p07.075
,2013, 'The Split Leg in Amyotrophic Lateral Sclerosis (P07.083)', Neurology, 80, http://dx.doi.org/10.1212/wnl.80.7_supplement.p07.083
,2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204
,2013, 'Pathophysiological insights into ALS with C9ORF72 expansions', Journal of Neurology, Neurosurgery and Psychiatry, 84, pp. 931 - 935, http://dx.doi.org/10.1136/jnnp-2012-304529
,2013, 'Physiology and pathophysiology of myelinated nerve fibers', , 115, pp. 43 - 53, http://dx.doi.org/10.1016/B978-0-444-52902-2.00004-7
,2013, 'Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology', , 116, pp. 561 - 575, http://dx.doi.org/10.1016/B978-0-444-53497-2.00045-0
,2013, 'Apparent anticipation in SOD1 familial amyotrophic lateral sclerosis', Amyotroph Lateral Scler Frontotemporal Degener, 14, pp. 452 - 456, http://dx.doi.org/10.3109/21678421.2013.764569
,2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360
,2013, 'Controversies and priorities in amyotrophic lateral sclerosis.', Lancet Neurology, 12, pp. 310 - 322, http://dx.doi.org/10.1016/S1474-4422(13)70036-X
,2013, 'Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes', Neurology, 80, pp. 1117 - 1123, http://dx.doi.org/10.1212/WNL.0b013e31828869da
,2013, 'Cortical excitability differences between flexor pollicis longus and APB', Neuroscience Letters, 541, pp. 150 - 154, http://dx.doi.org/10.1016/j.neulet.2013.03.003
,2013, 'Diagnostic shifts in ALS?: From clinical specter to imaging spectra.', Neurology, 80, pp. 606 - 607
,2013, 'Early saccades in amyotrophic lateral sclerosis', Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 14, pp. 294 - 301, http://dx.doi.org/10.3109/21678421.2013.783077
,2013, 'Effects of Axonal Ion-Channel Dysfunction on Quality of Life in Type 2 Diabetes.', Diabetes Care, 36, pp. 1272 - 1277, http://dx.doi.org/10.2337/dc12-1310
,